Skip to main content

Stem Cell Insight Turns Back the Clock on Tooth Decay

Researchers identified a stem cell population that declines during aging, but anti-aging drugs may help restore their regenerative potential.

Written byRJ Mackenzie
| 2 min read
A hand wearing a green glove grabs a decaying tooth from an open mouth.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

As people get older, teeth become more fragile and vulnerable to tooth decay. But younger teeth are more resilient. Within teeth are cells called odontoblasts that produce the important structural tissue dentin. Odontoblasts can help restore the integrity of damaged teeth by making more dentin, but this depends on the availability of a ready supply of dental pulp stem cells (DPSCs) to replace the odontoblasts. In older teeth, DPSCs stop working and produce fewer odontoblasts. The factors that change in older teeth and lead to a loss of odontoblasts remain unknown.

Now, researchers from Sichuan University have identified a key biological process underlying tooth aging and have shown a potential way to impede it. They found that a subset of DPSCs missing in older teeth, and a protein they produce, unlocked the regenerative abilities of younger teeth. The new study was published in Stem Cell Reports.1

How Aging Affects Teeth

The researchers recruited young (aged 18–40) and older (aged 60 and older) volunteers and removed their wisdom teeth. The team had previously reported that DPSCs expressing the protein nuclear factor of activated T cells 1 (NFATC1) were involved in the formation of new dental pulp.2

In the wisdom teeth samples, the researchers found that in stem cell populations derived from older teeth, NFATC1 protein had declined to the point of being undetectable. At the same time, older teeth were more vulnerable to decay. The authors tracked the teeth of volunteers with signs of tooth decay for one year. Older volunteers’ teeth were more likely to show irreversible decay progression over this time.

Continue reading below...

Like this story? Sign up for FREE Cell Biology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

They then examined DPSCs in mice. Like aged humans, older mice lacked NFATC1-expressing DPSCs.

To study how aging affects DPSCs in mice, the team genetically modified the mice so that they could suppress NFATC1-expressing stem cells in young mice. They saw that the dental pulp of younger mice lacking these cells went into a biological aging process called senescence. The researchers found that this was because NFATC1 was essential for the stem cells’ normal progression through the cell cycle. The dental pulp looked more like that of older mice, lacking odontoblasts. Young teeth lacking these cells were also less able to regenerate after injury.

Drugs Mitigate the Effects of Age-related Changes

But there was good news as well. In young adult mice with injured teeth who lacked the stem cells needed to repair the damage, anti-aging drugs called senolytics helped. The common senolytic drug combination—the cancer drug dasatinib with the plant pigment quercetin—removed cells undergoing senescence in the mice’s teeth. This helped restore levels of dentin formation to levels seen in control mice. The senolytics also improved dental pulp density and reduced the porosity of the mice’s teeth.

The team acknowledged that there were some limitations to their study. Only a small number of volunteers were recruited for the tooth analysis—just three per study arm—and the mouse model isn’t a perfect replica of natural aging. Still, the researchers wrote in the paper, “These findings advance our understanding of tooth aging and provide potential strategies for combating age-related dental decline.”

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • RJ Mackenzie

    RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years, where he also worked on the site’s SEO and editorial AI strategies. He created the site’s podcast, Opinionated Science, in 2020. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays